Skip Navigation LinksSecond-Extension-of-Congenital-Syphilis-Prevention-Funding_2021-2026 Second Extension of Congenital Syphilis Prevention Funding (January 2021 - January 2026)

State of Cal Logo

State of California—Health and Human Services Agency
California Department of Public Health


To: Congenital Syphilis Prevention Grantees
Second Extension of Congenital Syphilis Prevention Funding

The California Department of Public Health (CDPH), Sexually Transmitted Diseases Control Branch (STDCB) is pleased to inform the recipients of the Congenital Syphilis Prevention (CSP) funding that an additional extension has been announced by the Centers for Disease Control and Prevention (CDC). This second extension changes the previous extension date of 01/31/25 to 01/31/26 and includes additional funding.

As a reminder, funding for this grant is made possible through a cooperative agreement from the CDC. Below are the highlights of the federal award and a copy of the notice is also attached for reference.

  • Federal Grant Award Name: PS19-1901 - Strengthening STD Prevention and Control for Health Departments (PCHD)
  • Federal Grant Award Number: NH25PS005127
  • Assistance Listing Number (aka CFDA) Number: 93.977

Due to the announcement of this second extension of the grant funding, the first notification letter issued on August 21, 2023 is rescinded and will be replaced with this notice.

Along with the announcement of the 27-month funding extension, the CDC also informed CDPH the level of funding for the extension will not change. With this second time extension and the addition of funding, the amendments currently in progress will be revised to:

  • Change the grant agreement term end date from 12/31/23 to the new end date of 01/31/26.
  • Add additional same level funding for the periods of 01/01/24 – 01/31/25 and 02/01/25 – 01/31/26.
  • Update the grant activities document to allow more flexibility for grantees to spend down the remaining funding.

The change of the end date will not change the original effective date. With this amendment, the grants will have an effective period of January 1, 2021 through January 31, 2026.

CDPH has begun the amendment process and to expedite this grant amendment through the approval process, we request that you confirm your intention to accept this second extension and the additional funding no than Friday, October 13, 2023. Please submit a formal letter of acceptance via email to with a cc to​.

When e-mailing your intent to accept the additional funding to, please include your agency’s name in the subject line when you send the email to help us to easily identify which local health jurisdiction you represent. Please note that no funds are secured until the amendment is fully executed.

Budget revisions for the periods of 01/01/24 – 01/31/25 and 02/01/25 – 01/31/26 will need to be submitted and should include the projected amount to be spent. CDC has approved expanded authority permitting the rollover of unspent funds from calendar year 2023 through the end of January 2026. Budget revision requests for this period can be submitted after December 31, 2023, but no later than April 1, 2024. See Attachment 1 for the updated funding chart showing the amended grant award amounts.

New Flexibility in Use of CSP Grant Funds

The additional funding must be used to continue the CSP and control activities. However, the grant activities have been revised to allow more flexibility for the utilization of the funds. The Scope of Work (aka, grant activities) has been revised to expand syphilis and STI screening and prevention services in local emergency departments and jail settings as well as new optional activities for the Grantee to implement using this funding. These four new optional activities include: providing syphilis testing and prevention with integrated testing for HIV, HCV, chlamydia, gonorrhea, and mpox vaccination; however, there is a 10% cap on safety net clinical services/expenses, and this is based on the annual award amount. In addition to the expansion and integration of services, other optional activities include providing incentives to clients to encourage testing, treatment, and follow-up appointments (incentives are capped at 1% of the annual award); implementing a social marketing campaign; and to propose an innovative and impactful activity to increase client testing or prenatal services for at risk populations. A copy of the revised grant activities document is attached for reference.

If you have any questions, please feel free to contact Christine Johnson by e-mail at

Kathleen Jacobson Signature
Kathleen Jacobson, MD
Branch Chief
STD Control Branch


cc: Rachel Piper, Chief, Contracts and Purchasing Unit, STD Control Branch
Jessica Frasure-Williams, Chief, Program Development Section, STD Control Branch
Ashley Dockter, Evaluation and Quality Improvement Unit Chief, STD Control Branch
Meghan Polich, Congenital Syphilis Program Coordinator, STD Control Branch

Attachment 1



​Local Hea​lth Jurisdiction
​Current Funding Amounts
(Through 12/31/23)
Additional Funding
(Year 6) 
Additional Funding
(Year 7) 
(02/01/2025 - 01/31/2026)
​Long Beach
​San Bernardino
​San Joaquin

​Total Funding

California Department of Public Health - STD Control Branch​
850 Marina Bay Parkway, Building P, 2nd Floor, Richmond, CA 94804
(510) 620-3400 • FAX (916) 636-6212 • Internet Address: